- New study supports testing of Merck’s Ebola vaccine in DRC outbreakNew data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.STAT · 2d ago↗ source
- Vertex was sole bidder in high-premium Crinetics acquisition<p>Analysts expect new details on the lead-up to the deal “are likely to reignite” investor scrutiny that Vertex overpaid in what’s poised to be its largest-ever transaction.</p>BioPharma Dive · 2d ago↗ source
- GSK lung cancer drug gets speedy approval following $10.6B deal<figure><div><img src="https://imgproxy.divecdn.com/c0irKiK7j9tqBFXMPegw7r6KQcBI9zHl6OgHMT-b53A/g:nowe:0:353/c:4765:2692/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9OZXdfR1NLSC5qc…